Pages that link to "Q34408875"

The following pages link to Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor (Q34408875):

Displaying 20 items.

• Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer (Q28084346) (← links)
• Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer (Q35634258) (← links)
• One colon lumen but two organs (Q36179345) (← links)
• Biomarker-directed Targeted Therapy in Colorectal Cancer (Q38383343) (← links)
• Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter (Q39437966) (← links)
• Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy (Q39590420) (← links)
• Mitochondrial protein 18 (MTP18) plays a pro-apoptotic role in chemotherapy-induced gastric cancer cell apoptosis (Q41345691) (← links)
• Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer (Q41957159) (← links)
• Production of truncated MBD4 protein by frameshift mutation in DNA mismatch repair-deficient cells enhances 5-fluorouracil sensitivity that is independent of hMLH1 status (Q42386247) (← links)
• Effect of early preoperative 5-fluorouracil on the integrity of colonic anastomoses in rats (Q42547579) (← links)
• Secondary Prevention of Colorectal Cancer: Is There an Optimal Follow-up for Patients with Colorectal Cancer? (Q42921554) (← links)
• Antitumor activity of HPA3P through RIPK3-dependent regulated necrotic cell death in colon cancer. (Q51746738) (← links)
• Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy. (Q52649897) (← links)
• Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients (Q58698551) (← links)
• Silibinin, A Natural Blend In Polytherapy Formulation For Targeting Cd44v6 Expressing Colon Cancer Stem Cells (Q59329386) (← links)
• GATA6 enhances the stemness of human colon cancer cells by creating a metabolic symbiosis through upregulating LRH-1 expression (Q89617881) (← links)
• Risk factors for colon location of cancer (Q90068288) (← links)
• Discovery of N-phenyl-(2,4-dihydroxypyrimidine-5-sulfonamido) phenylurea-based thymidylate synthase (TS) inhibitor as a novel multi-effects antitumor drugs with minimal toxicity (Q91809371) (← links)
• TaqI and ApaI Variants of Vitamin D Receptor Gene Increase the Risk of Colorectal Cancer in a Saudi Population (Q99578841) (← links)
• 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation (Q100761822) (← links)